The Venture Codex Logo

The Venture Codex

Nexus NeuroTech Ventures

4 Embarcadero Center, 14th Floor, San Francisco, CA, 94111, United States

Overview

Venture capital firm specializing in neurotechnology investments.

Founded

2023

Deals · 12mo

3

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

Belgium
Israel
United States

Sector focus

—

Investment portfolio

8rounds
NAMEDATESIZE
Beacon Biosignals
Nov 2025Participated
$86 MSeries B
Modulight Biotherapeutics
Nov 2025Participated
$12 MSeed
Ampa
Oct 2025Led
$9 MSeries A
Nobi
Jan 2025Led
$41 MSeries B
Synapticure
Nov 2024Participated
$25 MSeries A
InSightec
Jun 2024Led
$150 MOther Equity
EarliTec Diagnostics
Apr 2024Led
$22 MSeries B
Rune Labs
Jan 2024Led
$12 MOther Equity
Beacon Biosignals
Nov 2025Participated
$86 MSeries B
Modulight Biotherapeutics
Nov 2025Participated
$12 MSeed
Ampa
Oct 2025Led
$9 MSeries A
Nobi
Jan 2025Led
$41 MSeries B
Synapticure
Nov 2024Participated
$25 MSeries A
InSightec
Jun 2024Led
$150 MOther Equity
EarliTec Diagnostics
Apr 2024Led
$22 MSeries B
Rune Labs
Jan 2024Led
$12 MOther Equity
8
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Nexus NeuroTech Ventures: 8 funding rounds are recorded in the selected participation categories.All available history.
Nexus NeuroTech Ventures: 8 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A11
Series B21
Other Equity20

Monthly Deal Activity

Nexus NeuroTech Ventures: 8 deals are recorded across 34 months.All available history.
Nexus NeuroTech Ventures: 8 deals are recorded across 34 months. All available history
MonthDeals
Jan '241
Feb '240
Mar '240
Apr '241
May '240
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '241
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '252
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Nexus NeuroTech Ventures: Health & Life Sciences is the largest displayed sector by deal count (7 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Nexus NeuroTech Ventures: Health & Life Sciences is the largest displayed sector by deal count (7 deals). All available history
SectorDeals
Health & Life Sciences7
AI & Machine Learning2
Hardware & Robotics1
Enterprise Software1
Manufacturing1
Space & Frontier Tech1
Consumer & Lifestyle1

Deal Size Distribution

Nexus NeuroTech Ventures: 8 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Nexus NeuroTech Ventures: 8 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M3
$25M-$50M2
$50M-$100M1
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Nexus NeuroTech Ventures: United States has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Nexus NeuroTech Ventures: United States has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
United States6
Europe1
Israel1
Nexus NeuroTech Ventures: 20 co-investors are shown, with Catalio Capital Management sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Nexus NeuroTech Ventures: 20 co-investors are shown, with Catalio Capital Management sharing 2 recorded deals. All available history
Co-investorShared deals
Catalio Capital Management2
Google Ventures2
15th Rock1
Ally Bridge Group1
Angelini Ventures1
B Capital Group1
Baillie Gifford1
Casdin Capital1
CommonSpirit Health1
Continuum Health Ventures1
CVS Health Ventures1
DigiTx Partners1
Eclipse Ventures1
EQT1
Fayez Sarofim & Co.1
Fidelity Management & Research Company1
Fresh Fund1
General Catalyst1
Gilmartin Capital1
Indicator Ventures1

Investment Strategy

Nexus NeuroTech Ventures: Led accounts for 63% and participating for 38% of round participation.All available history.
Nexus NeuroTech Ventures: Led accounts for 63% and participating for 38% of round participation. All available history
CategoryDeals (count)Share (%)
Led563%
Participating338%
Nexus NeuroTech Ventures: Single-lead accounts for 40% and co-led for 60% of lead dynamics.All available history.
Nexus NeuroTech Ventures: Single-lead accounts for 40% and co-led for 60% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead240%
Co-led360%

Team

John Propst, PhD, MBA
Jordi Parramon

CEO, General Partner and Co-founder

William J. Marks, Jr., MD, MS

CMO, General Partner, & Co-Founder